Neuphoria Therapeutics In... (NEUP)
NASDAQ: NEUP
· Real-Time Price · USD
6.90
-0.04 (-0.58%)
At close: Aug 20, 2025, 3:59 PM
Neuphoria Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Cash & Equivalents | 17.05M | 4.34M | 8.08M | 12.61M | n/a | 10.13M | n/a | 12.1M | 18.1M | 20.88M | 30.7M | 23.09M | 33.56M | 29.25M | 40.35M | 21.41M | 28.5M | 4.41M | 5.74M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 327.31K | n/a | n/a | n/a |
Long-Term Investments | 74.73K | 73.98K | 82.49K | n/a | n/a | 81.07K | n/a | n/a | n/a | 80.95K | 119K | n/a | n/a | 86.26K | n/a | 119K | n/a | 334.94K | 435.64K |
Other Long-Term Assets | -568 | 816.00 | 98.00 | 78.03K | n/a | n/a | n/a | 78.9K | 118.02K | n/a | n/a | 81.86K | 119K | n/a | 119K | -29.59K | 119K | n/a | n/a |
Receivables | 24.59K | 35.56K | 115.96K | 126.88K | n/a | 423.11K | n/a | 426.09K | n/a | 116.21K | 38.03K | 4.67M | n/a | 813.3K | 24.49K | 849.85K | 192.88K | 20.98K | 27.29K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.00 | n/a | 1.00 | n/a | n/a | n/a | 2.00 | n/a | n/a | n/a |
Other Current Assets | -489 | -30 | -68 | 351.00 | -15.54M | n/a | -18.83M | n/a | 637.34K | 0.00 | 132.78K | -0.00 | 6.78M | -0.00 | 1.1M | 327.31K | 1.37M | 698.25K | 908.17K |
Total Current Assets | 17.09M | 4.4M | 8.43M | 13.19M | n/a | 11.48M | n/a | 13.33M | 19.93M | 22.55M | 33.15M | 28.76M | 41.81M | 32.33M | 44.6M | 23.24M | 30.93M | 5.13M | 6.67M |
Property-Plant & Equipment | 126.84K | 152.2K | 199.41K | 218.97K | n/a | 283.5K | n/a | 333K | 498.1K | 400.28K | 588.39K | 464.01K | 674.53K | 550.56K | 759.49K | 654.37K | 870.94K | 502.87K | 654.04K |
Goodwill & Intangibles | 13.42M | 13.54M | 14.21M | 14.16M | n/a | 14.62M | n/a | 14.82M | 22.17M | 15.27M | 22.45M | 15.62M | 22.71M | 16.21M | 22.37M | 16.79M | 22.35M | 17.19M | 22.36M |
Total Long-Term Assets | 13.62M | 13.77M | 14.49M | 14.46M | n/a | 14.99M | n/a | 15.24M | 22.79M | 15.75M | 23.16M | 16.17M | 23.5M | 16.85M | 23.24M | 17.53M | 23.34M | 18.03M | 23.45M |
Total Assets | 30.71M | 18.17M | 22.92M | 27.65M | n/a | 26.47M | n/a | 28.56M | 42.72M | 38.31M | 56.31M | 44.93M | 65.31M | 49.18M | 67.84M | 40.77M | 54.26M | 23.16M | 30.13M |
Account Payables | 745.34K | 1.53M | 1.33M | 2.24M | n/a | 1.75M | n/a | 1.44M | 2.15M | 2.1M | 3.09M | 1.07M | 1.56M | 2M | 2.75M | 772.93K | 1.03M | 936.64K | 1.22M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 31.4K | 31.09K | 34.66K | 33.12K | n/a | 764.9K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.71M | 7.02M |
Other Current Liabilities | 255.87K | 31.59K | 112.24K | 328.89K | n/a | 381.93K | n/a | 72.56K | n/a | 275.23K | n/a | 281.57K | n/a | 294.52K | n/a | 279.45K | n/a | 332.4K | n/a |
Total Current Liabilities | 1.55M | 2.13M | 2.55M | 3.83M | n/a | 3.01M | n/a | 2.74M | 4.1M | 2.49M | 3.66M | 2.31M | 3.36M | 2.4M | 3.31M | 1.77M | 2.36M | 6.98M | 9.08M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.75M | 2.27M |
Other Long-Term Liabilities | 2.38M | 1.39M | 2.37M | 5.25M | -30.35M | 2.46M | -34.24M | 2.47M | 5.35M | 1.87M | 4.48M | 1.86M | 4.51M | 1.33M | 3.63M | 1.33M | 3.61M | 624.14K | 2.7M |
Total Long-Term Liabilities | 3.16M | 2.29M | 3.29M | 6.33M | -30.35M | 3.68M | -34.24M | 3.81M | 5.7M | 3.35M | 4.93M | 3.47M | 5.04M | 3.08M | 4.25M | 3.23M | 4.31M | 3.82M | 4.97M |
Total Liabilities | 4.72M | 4.42M | 5.85M | 10.16M | -30.35M | 6.69M | -34.24M | 6.55M | 9.8M | 5.84M | 8.59M | 5.78M | 8.4M | 5.48M | 7.56M | 5.01M | 6.67M | 10.8M | 14.05M |
Total Debt | 172.46K | 199.4K | 254.01K | 239.62K | n/a | 1.07M | n/a | 353.76K | 529.16K | 418.07K | 614.55K | 477.15K | 693.62K | 557.41K | 768.94K | 652.04K | 867.84K | 7.46M | 9.7M |
Common Stock | 19.00 | 16.00 | n/a | n/a | n/a | 159.3M | n/a | n/a | n/a | 152.05M | 223.5M | 149.75M | 217.7M | 155.31M | 214.25M | 142.9M | 190.19M | 117.12M | 152.33M |
Retained Earnings | -169.46M | -180.72M | -178.78M | -177.98M | n/a | -148.95M | n/a | -162.48M | -243.04M | -128.73M | -189.23M | -119.22M | -173.31M | -119.39M | -164.7M | -115.74M | -154.04M | -111.82M | -145.44M |
Comprehensive Income | -3.91M | -3.72M | -2.43M | -3.01M | 30.35M | 9.43M | 34.24M | -3.06M | -4.58M | 9.15M | 13.45M | 8.62M | 12.52M | 7.78M | 10.73M | 8.6M | 11.45M | 7.06M | 9.19M |
Shareholders Equity | 26M | 13.75M | 17.07M | 17.49M | 30.35M | 19.78M | 34.24M | 22.01M | 32.92M | 32.46M | 47.72M | 39.15M | 56.91M | 43.7M | 60.28M | 35.76M | 47.6M | 12.36M | 16.08M |
Total Investments | 74.73K | 73.98K | 82.49K | n/a | n/a | 81.07K | n/a | n/a | n/a | 80.95K | 119K | n/a | n/a | 86.26K | n/a | 446.31K | n/a | 334.94K | 435.64K |